SAN FRANCISCO--(BUSINESS WIRE)--Fermiscan Holdings Limited, which is commercializing a non-invasive diagnostic test for breast cancer, today announced that David Young, Chief Executive Officer, will present at Merriman Curhan Ford’s 5th Annual Investor Summit on September 15, 2008 at 4.00 pm. This event will be held at the Mark Hopkins InterContinental Hotel in San Francisco.
